Pia Banerjee, PhD

Pia Banerjee, PhD

  • Clinical Research Neuropsychologist



BS – Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts
MA – Washington University in St. Louis, St. Louis, Missouri
PhD – Washington University in St. Louis, St. Louis, Missouri

Current Research

  • Brain Integrity in Survivors of Hodgkin Lymphoma Treated with Thoracic Radiation (BRIGHT), Co-Investigator
  • Risk of Psychopathology and Neurocognitive Impairment in Leukemia Survivors (NEULS), Co-Investigator
  • Treatment for Executive Dysfunction in Adult Survivors of Childhood Acute Lymphoblastic Leukemia (ALLSTIM), Co-Investigator
  • Healthy Kids after Cancer: A Physical Activity and Nutrition Intervention (HKAC), Co-Investigator

Research Interests

  • Patterns and predictors of neurocognitive function in cancer survivors
  • Association between brain integrity and genomic, molecular, and neuroimaging biomarkers
  • Late effects of cancer therapy
  • Remediation of executive function, attention, and memory difficulties

Selected Publications

Banerjee P, Leu K, Harris RJ, Cloughesy TF, Lai A, Nghiemphu PL, Pope WB, Bookheimer SY, Ellingson BM. Association between tumor location and neurocognitive functioning in adult glioma using voxel-based lesion-symptom mapping. NeuroImage: Clinical 9:617-624, 2015.

Banerjee P, White DA. Clinical assessment of organizational strategy: An examination of healthy adults. Psychological Assessment 27(2):726-732, 2015.

Banerjee P, Grange DK, Steiner RD, White DA. Executive strategic processing during verbal fluency performance in children with phenylketonuria. Child Neuropsychology 17(2):105-117, 2011.

Karzon R, Banerjee P. Animated toys versus video reinforcement in 16 to 24 month-old children in a clinical setting. American Journal of Audiology 19:91-99, 2010.

Cuff A, Banerjee P, Azhdam B. Managing for oncology growth, Volume II: Best practices for expanding access to care. Washington, DC: The Advisory Board Company. 232p, 2008.

Cuff A, Banerjee P, Azhdam B. Managing for oncology growth, Volume I: Best practices for increasing efficiency. Washington, DC: The Advisory Board Company. 214p, 2007.

Contos B, Pfenninger D, Banerjee P, Martsolf GR, Measells K. Outlook for medical cardiology: Five-year technology and business assessment. Washington, DC: The Advisory Board Company. 249p, 2007.

Siegler A, Cuff A, Banerjee P, Martsolf GR. Cancer center of the future: Strategic blueprint and management imperatives for new therapies and services. Washington, DC: The Advisory Board Company. 263p, 2006.

Pfenninger D, Banerjee P. Quality-based competition: Best practices for optimizing cardiac quality reporting. Washington, DC: The Advisory Board Company. 149p, 2006.

Herrington J, Zhou YP, Bugianesi RM, Duslki PM, Feng Y, Warren VA, Smith MM, Kohler MG, Garsky VM, Sanchez M, Wagner M, Raphaelli K, Banerjee, P, Ahaghotu C, Wunderler D, Priest BT, Mehl JT, Garcia ML, McManus OB, Kaczorowski GJ, Slaughter RS. Blockers of the delayed-rectifier potassium current in pancreatic β-cells enhance glucose-dependent insulin secretion. Diabetes 55:1034-1042, 2006.

Yan L, Herrington J, Goldberg E, Dulski PM, Bugianesi RM, Slaughter RS, Banerjee P, Brochu RM, Priest BT, Kaczorowski GJ, Rudy B, Garcia ML. Stichodactyla helianthus peptide, a pharmacological tool for studying Kv3.2 channels. Molecular Pharmacology 67(5):1513-1521, 2005.

Banerjee P. Recognition of c-ros oncogene inhibition with a FRET-based reporter construct. MIT Undergraduate Research Journal 10:52-57, 2004.

Last update: January 2016